Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Bone Marrow Transplant. 2011 Jan 24;46(12):1503–1509. doi: 10.1038/bmt.2010.339

Table 2.

Patient Outcomes

Outcome N
No. of Pts. with ANC ≤ 500 10
Time to Neutrophil Engraftment in days, median (range) 14 (11, 35)
No. of Pts. with Platelets ≤ 20 000 8
Time to Platelet Engraftment in days, median (range) 20 (11, 163)
Day 30 donor chimerism % - median (range). n = 11 97 (12)
Day 100 donor chimerism % - median (range). n = 9 98 (7)
Day 365 donor chimerism % - median (range). n = 6 100 (1)
gr. II–IV aGVHD 4
gr. III–IV aGVHD 1
cGVHD 7
No. of Relapses 1
No. of Deaths 2
 Sepsis/GVHD 1
 Infection 1

Outcome % Estimate (SE)

Cum. Inc. gr. II–IV aGVHD at 100 days 17% (11%)
Cum. Inc. gr. II–IV aGVHD at 200 days 25% (13%)
Cum. Inc. cGVHD at 12 months 63% (19%)
Cum. Inc. NRM at 12 months 18% (12 %)
PFS 2-year 74% (13 %)
OS 2-year 83% (11%)